Cargando…

The Efficacy and Renal Protective Effect of Tolvaptan in Chronic Kidney Disease Patients after Open-Heart Surgery

Purpose: Unlike loop diuretics, tolvaptan is reported to have a renal protective effect. The purpose of this study was to retrospectively assess the efficacy of tolvaptan administration in chronic kidney disease (CKD) patients following open-heart surgery. Methods: From February 2017 to August 2020,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Futamura, Yasuhiro, Watanuki, Hirotaka, Okada, Masaho, Sugiyama, Kayo, Matsuyama, Katsuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560536/ https://www.ncbi.nlm.nih.gov/pubmed/34053960 http://dx.doi.org/10.5761/atcs.oa.20-00364

Ejemplares similares

Surgical repair of massive dilatation of the right atrium with tricuspid regurgitation
por: Okada, Masaho, et al.
Publicado: (2018)

Unusual rupture of left ventricular pseudo-false aneurysm secondary to subacute anterolateral myocardial infarction: a case report
por: Okada, Masaho, et al.
Publicado: (2019)

Surgical treatment for brachiocephalic artery aneurysm with Takayasu arteritis using isolated cerebral perfusion: a case study
por: Sugiyama, Kayo, et al.
Publicado: (2021)

Resternotomy and coronary artery bypass grafting after omental flap procedure: A case report
por: Sugiyama, Kayo, et al.
Publicado: (2020)

Impact of direct carotid artery perfusion in acute type A aortic dissection involving the common carotid artery
por: Sugiyama, Kayo, et al.
Publicado: (2021)

Ventricular septal rupture after blunt chest trauma: a case report
por: Tochii, Masato, et al.
Publicado: (2022)

Impact of the Isolated Cerebral Perfusion Technique for Aortic Arch Aneurysm Repair in Patients with a Shaggy Aorta
por: Sugiyama, Kayo, et al.
Publicado: (2022)

Free‐wall perforation of the left ventricle after acute myocardial infarction complicated with pericardial tamponade that mimicked ascending aortic dissection: A case report
por: Sugiyama, Kayo, et al.
Publicado: (2022)

Impact of GERAADA score in patients with acute type A aortic dissection
por: Sugiyama, Kayo, et al.
Publicado: (2022)

A modified sutureless repair for left pulmonary vein obstruction after catheter ablation
por: Matsuyama, Katsuhiko, et al.
Publicado: (2022)

Surgical revascularization for severe spasm in the left main coronary artery
por: Sugiyama, Kayo, et al.
Publicado: (2023)

Fracture and embolization of a metal stent after a frozen elephant trunk procedure
por: Watanuki, Hirotaka, et al.
Publicado: (2023)

Effective treatment of severe stenosis of the carotid and coronary arteries: a case study
por: Sugiyama, Kayo, et al.
Publicado: (2023)

Efficacy and safety of tolvaptan for refractory fluid collection and edema in the terminal cancer patients
por: Tsuzuki, Norimasa, et al.
Publicado: (2023)

Efficacy of tolvaptan on advanced chronic kidney disease with heart failure: a randomized controlled trial
por: Komiya, Shiro, et al.
Publicado: (2022)

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
por: Katsumata, Mari, et al.
Publicado: (2017)

The efficacy of tolvaptan for heart failure in chronic kidney disease: A protocol for systematic review and meta-analysis
por: Zhu, Zhi-Yong, et al.
Publicado: (2022)

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction
por: Matsue, Yuya, et al.
Publicado: (2017)

Total body fluid is the factor that affects the pharmacokinetics of tolvaptan, and its efficacy, in acute worsening heart failure patients
por: Kato, Takahiro, et al.
Publicado: (2023)

Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload
por: Suzuki, Shunji, et al.
Publicado: (2018)

Tolvaptan
por: Rangarajan, Bharath, et al.
Publicado: (2014)

Redo mitral valve replacement in an adult with severe pulmonary hypertension resulting from structural valve deterioration and left ventricular outflow tract obstruction and a history of atrioventricular septal defect repair: a case report
por: Sugiyama, Kayo, et al.
Publicado: (2023)

Hemodynamic and Hormonal Effects of Tolvaptan for Heart Failure
por: Kiuchi, Shunsuke, et al.
Publicado: (2018)

Impact of renal function on mid-term outcomes in heart failure patients treated with tolvaptan
por: Fujioka, Kensuke, et al.
Publicado: (2019)

The effects of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure
por: Otsuka, Tomoyuki, et al.
Publicado: (2013)

Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure
por: Ikeda, Shuntaro, et al.
Publicado: (2017)

Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma
por: Miyazaki, Masayuki, et al.
Publicado: (2017)

Tolvaptan in ADPKD Patients With Very Low Kidney Function
por: Torres, Vicente E., et al.
Publicado: (2021)

Tolvaptan Improves Contrast-Induced Acute Kidney Injury
por: Xu, Chunyang, et al.
Publicado: (2022)

Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure
por: Jujo, Kentaro, et al.
Publicado: (2016)

Combination of tolvaptan and valsartan improves cardiac and renal functions in doxorubicin-induced heart failure in mice
por: Yan, Fengqin, et al.
Publicado: (2022)

Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016)

Long-Term Tolvaptan Treatment in Refractory Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2019)

Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites
por: Arase, Yoshitaka, et al.
Publicado: (2018)

Tolvaptan add-on therapy and its effects on efficacy parameters and outcomes in patients hospitalized with heart failure
por: Kansara, Tikal, et al.
Publicado: (2022)

Efficacy and safety of intravenous OPC‐61815 compared with oral tolvaptan in patients with congestive heart failure
por: Sato, Naoki, et al.
Publicado: (2022)

THU239 Tolvaptan For SIADH Management In Children
por: Igarashi, Mizuho, et al.
Publicado: (2023)

Tolvaptan in the Treatment of Acute Hyponatremia Associated with Acute Kidney Injury
por: Gopinath, Shilpa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lpo6a912vd8ankn95jfsul5946